关注
Bhagwat Prasad
Bhagwat Prasad
Associate Professor, Pharmaceutical Sci, Director, PRINCE, Washington State University, Spokane, WA
在 wsu.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine
M Drozdzik, C Gröer, J Penski, J Lapczuk, M Ostrowski, Y Lai, B Prasad, ...
Molecular pharmaceutics 11 (10), 3547-3555, 2014
2752014
Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs
S Singh, B Prasad, AA Savaliya, RP Shah, VM Gohil, A Kaur
TrAC Trends in Analytical Chemistry 28 (1), 13-28, 2009
2092009
Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem …
B Prasad, R Evers, A Gupta, CECA Hop, L Salphati, S Shukla, ...
Drug Metabolism and Disposition 42 (1), 78-88, 2014
2032014
Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics
L Wang, B Prasad, L Salphati, X Chu, A Gupta, CECA Hop, R Evers, ...
Drug Metabolism and Disposition 43 (3), 367-374, 2015
1942015
Interindividual variability in cytochrome P450–mediated drug metabolism
TS Tracy, AS Chaudhry, B Prasad, KE Thummel, EG Schuetz, X Zhong, ...
Drug Metabolism and Disposition 44 (3), 343-351, 2016
1642016
Metabolite identification by liquid chromatography-mass spectrometry
B Prasad, A Garg, H Takwani, S Singh
TrAC Trends in Analytical Chemistry 30 (2), 360-387, 2011
1452011
Abundance of drug transporters in the human kidney cortex as quantified by quantitative targeted proteomics
B Prasad, K Johnson, S Billington, C Lee, GW Chung, CDA Brown, ...
Drug Metabolism and Disposition 44 (12), 1920-1924, 2016
1432016
Ontogeny of hepatic drug transporters as quantified by LC‐MS/MS proteomics
B Prasad, A Gaedigk, M Vrana, R Gaedigk, JS Leeder, L Salphati, X Chu, ...
Clinical Pharmacology & Therapeutics 100 (4), 362-370, 2016
1402016
Ten years’ experience with the CYP2D6 activity score: a perspective on future investigations to improve clinical predictions for precision therapeutics
A Gaedigk, JC Dinh, H Jeong, B Prasad, JS Leeder
Journal of personalized medicine 8 (2), 15, 2018
1382018
Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotype
B Prasad, Y Lai, Y Lin, JD Unadkat
Journal of pharmaceutical sciences 102 (3), 787-793, 2013
1232013
Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics
B Prasad, JD Unadkat
The AAPS journal 16, 634-648, 2014
1172014
Cytochrome P450-dependent catabolism of vitamin K: ω-hydroxylation catalyzed by human CYP4F2 and CYP4F11
KZ Edson, B Prasad, JD Unadkat, Y Suhara, T Okano, FP Guengerich, ...
Biochemistry 52 (46), 8276-8285, 2013
1062013
Age‐and genotype‐dependent variability in the protein abundance and activity of six major uridine diphosphate‐glucuronosyltransferases in human liver
DK Bhatt, A Mehrotra, A Gaedigk, R Chapa, A Basit, H Zhang, ...
Clinical Pharmacology & Therapeutics 105 (1), 131-141, 2019
1042019
Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2): quantification by liquid chromatography/tandem mass spectrometry
AK Deo, B Prasad, L Balogh, Y Lai, JD Unadkat
Drug Metabolism and Disposition 40 (5), 852-855, 2012
942012
Toward a consensus on applying quantitative liquid chromatography‐tandem mass spectrometry proteomics in translational pharmacology research: a white paper
B Prasad, B Achour, P Artursson, CECA Hop, Y Lai, PC Smith, J Barber, ...
Clinical Pharmacology & Therapeutics 106 (3), 525-543, 2019
912019
Age-dependent absolute abundance of hepatic carboxylesterases (CES1 and CES2) by LC-MS/MS proteomics: application to PBPK modeling of oseltamivir in vivo pharmacokinetics in …
M Boberg, M Vrana, A Mehrotra, RE Pearce, A Gaedigk, DK Bhatt, ...
Drug Metabolism and Disposition 45 (2), 216-223, 2017
862017
Developmental regulation of drug-processing genes in livers of germ-free mice
FP Selwyn, SL Cheng, TK Bammler, B Prasad, M Vrana, C Klaassen, ...
Toxicological Sciences 147 (1), 84-103, 2015
802015
Abundance of phase 1 and 2 drug-metabolizing enzymes in alcoholic and hepatitis C cirrhotic livers: a quantitative targeted proteomics study
B Prasad, DK Bhatt, K Johnson, R Chapa, X Chu, L Salphati, G Xiao, ...
Drug Metabolism and Disposition 46 (7), 943-952, 2018
792018
Screening of Indian aphrodisiac ayurvedic/herbal healthcare products for adulteration with sildenafil, tadalafil and/or vardenafil using LC/PDA and extracted ion LC–MS/TOF
AA Savaliya, RP Shah, B Prasad, S Singh
Journal of pharmaceutical and biomedical analysis 52 (3), 406-409, 2010
782010
Interindividual and regional variability in drug transporter abundance at the human blood–brain barrier measured by quantitative targeted proteomics
S Billington, L Salphati, CECA Hop, X Chu, R Evers, D Burdette, ...
Clinical Pharmacology & Therapeutics 106 (1), 228-237, 2019
752019
系统目前无法执行此操作,请稍后再试。
文章 1–20